Crown Bioscience

About Crown Bioscience

Crown Bioscience is a premier Contract Research Organization (CRO) specializing in preclinical and translational services for oncology and immuno-oncology drug discovery and development. They equip biotech and pharmaceutical companies globally with advanced in vivo and in vitro models, biospecimen solutions, and comprehensive biomarker and data science capabilities. Driven by a mission to improve human health worldwide, Crown Bioscience is recognized for its excellence in global operations, evidenced by multiple international facilities in Suzhou, San Diego, and North Carolina. The company helps accelerate research by providing high-quality, clinically relevant results, a commitment reflected in its achievement of 845 studies completed with an impressive 96% customer satisfaction rate in Q4 2024.